Erythropoietin Attenuates Cardiac Dysfunction in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Diabetic Cardiomyopathy Jing LuQi-ming DaiYu-yu Yao ORIGINAL ARTICLE 04 August 2017 Pages: 367 - 379
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216 Joannes A. A. ReijersD. G. KallendM. Moerland ORIGINAL ARTICLE Open access 26 August 2017 Pages: 381 - 389
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials J. J. BrugtsM. BertrandE. Boersma ORIGINAL ARTICLE Open access 31 August 2017 Pages: 391 - 400
Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction? Masanori AsakuraJiyoong KimABC investigators ORIGINAL ARTICLE 04 August 2017 Pages: 401 - 411
Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease? Hayang YangBerto J. BoumaOn behalf of The Non vitamin K antagonist Oral anticoagulants for ThromboEmbolic prevention in adult congenital heart disease (NOTE) investigators SHORT COMMUNICATION Open access 07 August 2017 Pages: 413 - 417
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis Kamal AwadDimitri P. Mikhailidison behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group REVIEW ARTICLE 24 July 2017 Pages: 419 - 431
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease Paul P. DobeshManesh Patel REVIEW ARTICLE Open access 02 September 2017 Pages: 433 - 444
Navigating the Future of Cardiovascular Drug DevelopmentāLeveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference Thomas J. PovsicRob ScottMatthew T. Roe REVIEW ARTICLE 22 July 2017 Pages: 445 - 458
Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus Scott L. PurgaMandeep SidhuJoshua Schulman-Marcus ORIGINAL ARTICLE 04 September 2017 Pages: 459 - 470
The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety Hania K. FlatenAndrew A. Monte REVIEW ARTICLE 24 July 2017 Pages: 471 - 482
Erratum to: Vasodilator Therapy: Nitrates and Nicorandil Jason M. TarkinJuan Carlos Kaski Erratum Open access 14 August 2017 Pages: 483 - 483